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Abstract
Background: screening for frailty might help to prevent adverse outcomes in hospitalised older adults.
Objective: to identify the most predictive and efﬁcient screening tool for frailty.
Design and setting: two consecutive observational prospective cohorts in four hospitals in the Netherlands.
Subjects: patients aged ≥70 years, electively or acutely hospitalised for ≥2 days.
Methods: screening instruments included in the Dutch Safety Management Programme [VeiligheidsManagementSysteem (VMS)]
on four geriatric domains (ADL, falls, undernutrition and delirium) were used and the Identiﬁcation of Seniors At Risk, the
6-item Cognitive Impairment Test and the Mini-Mental State Examination were assessed. Three months later, adverse
outcomes including functional decline, high-healthcare demand or death were determined. Correlation and regression tree
analyses were performed and predictive capacities were assessed.
Results: follow-up data were available of 883 patients. All screening instruments were similarly predictive for adverse outcome
(predictive power 0.58–0.66), but the percentage of positively screened patients (13–72%), sensitivity (24–89%) and speciﬁcity
(35–91%) highly differed. The strongest predictive model for frailty was scoring positive on ≥3 VMS domains if aged 70–80
years; or being aged ≥80 years and scoring positive on ≥1 VMS domains. This tool classiﬁed 34% of the patients as frail with
a sensitivity of 68% and a speciﬁcity of 74%. Comparable results were found in the validation cohort.
Conclusions: the VMS-tool plus age (VMS+) offers an efﬁcient instrument to identify frail hospitalised older adults at risk for
adverse outcome. In clinical practice, it is important to weigh costs and beneﬁts of screening given the rather low-predictive
power of screening instruments.
Keywords: hospitalised older adults, frailty, screening, predictive power
Introduction
Hospitalisation is a hazardous event for older adults. The inci-
dence rate of subsequent adverse outcomes such as functional
decline and loss of independence has been reported to be high
[1–5] and often permanent [6, 7]. Many studies have been con-
ducted to ﬁnd a powerful screening tool to identify older patients
at an increased risk for adverse outcomes. The predictive
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performances of these tools have been summarised and com-
pared in reviews concluding that none of the instruments investi-
gated had a strong predictive power and could be considered a
‘gold standard’ [8–12]. In addition to predictive performance, ef-
ﬁciency, feasibility in clinical practice and face-validity were con-
sidered important for a screening instrument [12, 13].
As part of the transitional intervention project ‘Recovery
Care Programme’ (HerstelZorgProgramma), we aimed to imple-
ment a systematic approach to identify frail older patients in an
early stage of hospitalisation. The current article reports on
selecting a screening model for the identiﬁcation of frail older
adults who were at an increased risk for adverse outcomes.
In Dutch Hospitals, systematic screening of older patients
on undernutrition, ADL limitations, falls and delirium [14]
has been nationally implemented as part of a mandatory
programme (VeiligheidsManagementSysteem= Safety Management
Programme) (VMS) since 2012. The results of the screening
on these four important geriatric domains were tested for their
feasibility to predict adverse outcomes. Subsequently, we tested
whether other instruments previously described in the literature
improved the predictive power of the screening algorithm.
Methods
Participants
From 1 October 2010 to 1 February 2011 older adults aged
≥70 years, who were admitted to one of four participating hos-
pitals, were approached to participate in the study. In three hos-
pitals, elective and acute patients at the orthopaedic, neurology,
urology and surgical units participated. In one hospital, only
acute patients were approached to participate, independent of
the unit they were admitted to. Patients were eligible if they
stayed in the hospital for at least two consecutive days and if
they were interviewed within 72 h after admission. Patients with
severe cognitive impairment [Mini-Mental State Examination
(MMSE) <19] were excluded if no informal caregiver was avail-
able for a hetero-anamnesis.
From 1 October 2011 until 1 February 2012, a second
cohort was included, applying the same methods and criteria,
to validate the results. In this cohort, a short interview was
administered, including only questions needed for the assess-
ment of the screening tool established using the original data.
Before the start of the study, the medical ethical commit-
tee of the Leiden University Medical Center decided no
formal ethical assessment of the protocol was necessary
because the aim of the study was to evaluate the quality of
care for (frail) older people. All the patients received detailed
written information before they were interviewed, and could
thereafter refuse to participate. Patient data were anonymised
immediately after collection.
Measurements
Trained nurses administered an interview on demographic
information, the unit of admission and type of admission
(acute/elective) and the instruments that are described below.
Three and twelve months after their admission date, patients
were sent a self-administered questionnaire to measure their
level of functioning.
Screening instruments
The six-item Katz Index on Independence in Activities in
Daily Living [15] was used to assess functional status. Patients
were asked whether they needed help bathing, dressing, toilet-
ing, transferring from bed to a chair and eating and whether
they used incontinence materials (yes/no). A patient was con-
sidered dependent if having a score of ≥2. The risk for falls
was assessed with a single question on whether the patient fell
in the last six months (yes/no). A patient was considered to be
(at increased risk to become) undernourished when having
either lost weight unintentionally and/or having experienced a
decreased appetite and used supplemental drinks or tube
feeding. A patient was considered to be at risk for delirium if
one or more of three questions was answered with ‘yes’:
memory problems, the need for help with self-care and previ-
ously experienced confusion. These four instruments (on
ADL, falls, undernutrition and delirium) make up the Dutch
VMS screening programme. We composed a VMS total score
by adding up the patients’ dichotomised screening results on
the four domains, resulting in a score from 0 to 4.
The Identiﬁcation of Seniors at Risk (ISAR) [16] screening
instrument, developed to identify older patients at risk for a
functional decline in emergency departments, was assessed.
Its six items concerning the need for help with self-care and
household activities, previous hospital admission in the last
6 months, vision, memory and polypharmacy add up to a sum
score of 0–6 and a score of ≥2 implicates an increased risk.
Two cognitive tests were assessed, the 6-item Cognitive
Impairment Test (6CIT) and the MMSE. The 6CIT [17]
includes one memory, two attention and three orientation
questions, resulting in a score ranging from 0 (best) to 28.
Patients with a score >10 are considered to have cognitive
impairment. The MMSE items cover the cognitive functions
orientation, memory, attention and calculation, language and
the ability to follow simple comments [18]. The maximum
score is 30 and patients with a score of ≤23 are considered
to have cognitive impairment.
Outcome
The outcome was the occurrence of an adverse outcome
within 3 months after hospital admittance. Adverse outcome
was deﬁned by a decline of ADL function and/or a high-
healthcare demand or death. Functional decline was consid-
ered present if patients reported one or more additional ADL
dependencies on the Katz Index after 3 months of follow-up.
Healthcare demand was assessed using information obtained
from the healthcare insurer on the patients’ indicated budget
for long-term care. Patients were considered to have a high-
healthcare demand if being indicated a budget that gives
access to a sheltered living area with intensive care. Deaths
were checked in the systems of the hospital and the healthcare
insurer or were reported by family members after receiving the
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follow-up questionnaire. Adverse outcomes were assessed
again after 12 months of follow-up.
Analyses
Candidate determinants for inclusion in the prediction model
were selected based on their relative risks for adverse outcome
after 3 months of follow-up. The sensitivity, speciﬁcity and
predictive power of these candidate predictors were calculated
in association with adverse outcome. Next, classiﬁcation and
regression trees (CART) [19] were composed that divided the
sample in subgroups as homogeneous as possible with regard
to the outcome by selecting the most predictive variables
based on minimum prediction error. First, only determinants
that are readily available of every patient admitted in Dutch
hospitals were used to compose a classiﬁcation tree: age, type
of admission (acute/elective) and the data included in the
VMS system. The other candidate predictors were subsequent-
ly added to the model, and ﬁnally they were all added at the
same time. Based on these models, high- and low-risk groups
were composed; patients in branches of the tree with a risk for
adverse outcomes that was higher than the background risk in
the total study population were considered to be at ‘high risk’.
Calculations of the sensitivity, speciﬁcity and power to predict
adverse outcomes after 3 months of follow-up were used to
compare the different models. Analyses were performed using
SPSS, version 20.0 (IBM Corp., Armonk, NY, USA).
This work was supported by the Netherlands Organization
for Health Research and Development (ZonMw). The
funding organisation had no role in the design or conducts of
the study, nor in the data collection and analyses, the interpret-
ation of the data or the realisation process of the manuscript.
Results
Supplementary data available in Age and Ageing online,
Figure S1 show details on the inclusion and drop-out in both
the initial and the validation cohort. Baseline characteristics
of both cohorts are displayed in Table 1. In Table 2, the rela-
tive risks for adverse outcome and the predictive capacities
of the candidate predictors are displayed. Apart from sex, all
determinants were statistically signiﬁcantly associated with an
adverse outcome. The percentage of the population that
scored positive on the different determinants ranged from 13
to 72%. The sensitivity of the tests varied from 24 to 89%,
the speciﬁcity from 35 to 91%, and the AUC from 0.58 to
0.66 over the different predictors. Age and two or more posi-
tive scores on the VMS domains were the strongest predic-
tors of an adverse outcome.
The tree displayed in Figure S2, Supplementary data avail-
able in Age and Ageing online, was composed by the perform-
ance of a CART analysis including age, type of admittance
and all information extracted from the VMS screening.
Placing the strongest predictor of adverse outcome in the top
of the tree, the population was split ﬁrstly by age (70–80
versus ≥80 years). For the second split, the number of
positively screened domains of VMS was selected in both
branches of the tree. When splitting the branch of patients
aged 70–80 years, the optimal cut-off of this VMS total score
was ≥3. For the patients aged ≥80 years, the cut-off value of
≥1 created two optimally homogenous groups for the risk
for an adverse outcome. The predictive capacities of this
model are displayed in Table 3.
When adding other instruments to the model, only the
MMSE had enough predictive power to be included in the re-
gression tree: patients aged over 80 years, without a positive
score on the VMS domains were considered positive if they
scored ≤23 on the MMSE. This combination was only present
in three patients in our population, so the extra step in the deci-
sion tree did not change the measures of predictive power.
Table 3 also shows that the screening model predicted
adverse outcome after 12 months of follow-up with a sensi-
tivity of 66%, a speciﬁcity of 72% and a predictive power of
0.69. In the validation cohort, a sensitivity of 61%, a speciﬁ-
city of 75% and a predictive power of 0.68 were found.
Discussion
We studied the capacity to predict an adverse outcome 3
months after hospitalisation in older adults of several screen-
ing instruments for geriatric conditions and demographic in-
formation separately, as well as in all possible combinations.
The predictive power of the individual instruments was simi-
larly poor, the sensitivities, speciﬁcities and percentages of
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Characteristics of patients included in the initial and
validation cohort for longitudinal analyses
Initial cohort Validation cohort
N 883 812
Sex (% male) 46.0 45.8
Age [median (IQR)] 78 (9) 78 (10)
Acute admittance (%) 45.2 41.4
Length of stay in days, [median (IQR)] 6 (6) 5 (6)
Medical specialty (%)
General surgery 36.7 28.1
Orthopaedics 27.3 38.9
Neurology 14.0 14.2
Urology 15.5 14.7
Other 6.2 4.3
VMS undernutrition* (%) 27.7 27.6
VMS delirium (range 0–3, % ≥1) 55.2 44.3
VMS ADL limitations (range 0–6, % ≥2) 23.3 15.7
VMS falls (%) 37.6 36.4
VMS sum score [median (IQR)] 1 (2) 1 (2)
MMSE (range 0–30, % ≤23) 15.9 –
6CIT (range 0–28, % >10) 13.2 –
ISAR (range 0–6, % ≥2) 57.1 –
IQR, inter-quartile range; VMS, VeiligheidsManagementSysteem, Safety Management
Programme; ADL, activities of daily living; MMSE, Mini-Mental State
examination; 6CIT, 6-item Cognitive Impairment Test; ISAR, Identification of
Seniors at Risk.
*VMS undernutrition (lost weight and/or both less appetite as well as energy
supplement use).
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patients screened positive widely differed. Combining age and
instruments screening for (the risk for) undernutrition, ADL
limitations, falls and delirium (domains of VMS) improved the
power to predict adverse outcomes. Adding other instruments
to the model did not further improve the prediction. The best
predictive power for adverse outcome was found identifying
patients at risk when aged 70–80 years and scoring positive on
three or four VMS domains; or when aged ≥80 years and
scoring positive on one or more of the VMS domains. This
VMS plus age (VMS+) screening tool showed both an accept-
able sensitivity (68%) and speciﬁcity (74%), without the ma-
jority of patients screening positive (34%).
Several studies and reviews previously investigated instru-
ments to predict adverse outcomes in hospitalised older
patients. The power to predict adverse outcomes using several
commonly studied instruments, such as ISAR, KATZ-ADL
and SHERPA, was shown not to differ much [8–12, 20, 21]
and no instrument met the criteria of a gold standard. Few
studies [9–11] previously studied several screening instruments
within the same population, but to our knowledge,
combinations of instruments have not been studied
before. No previous studies used the (VMS) screening instru-
ments on four main geriatric problems to predict adverse
outcome after hospitalisation. The separate domains did not
satisfactory predict the incidence of adverse outcome, but the
number of positively scored domains added to the predictive
capacity.
In an additional subgroup analysis, we separated acutely and
electively admitted patients because the results of the screening
can have distinctive implications for the management of care in
these groups. The VMS+ screening appeared to be highly sensi-
tive (82%) in the acute patients and highly speciﬁc (80%) in the
elective patients. This increased sensitivity and speciﬁcity came
at the cost of a decreased speciﬁcity and sensitivity, respectively.
The validity of performing the screening in elective patients
before admission in order to be able to plan preventive mea-
sures warrants future research. The low percentage of false-
positive results of the VMS+ screening in electively admitted
patients gives hope that the instrument might be applicable for
that purpose.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Bivariate associations of all determinants with adverse outcome after 3 months of follow-up and their individual
power to predict an adverse outcomea after 3 months of follow-up
Determinant RR 95% CI % of population
screened positive
Sensitivity (%) Specificity (%) PPV (%) NPV (%) AUC
Female sex 1.08 0.87–1.33
Age (≥80 versus <80 years) 2.17 1.77–2.68 38 62 70 44 83 0.66
Admittance type (acute versus elective) 1.89 1.53–2.33 43 58 63 37 80 0.61
VMS undernutrition 1.93 1.57–2.38 27 40 78 40 78 0.59
VMS delirium (≥1) 2.85 2.18–3.73 47 62 59 37 80 0.61
VMS ADL limitations (≥2) 2.19 1.77–2.70 16 28 88 46 77 0.58
VMS falls 1.97 1.59–2.44 38 54 68 38 80 0.60
VMS total ≥1 3.36 2.28–4.95 72 89 35 33 90 0.62
VMS total ≥2 2.77 2.18–3.52 43 67 66 42 84 0.66
MMSE (≤23) 2.19 1.77–2.71 15 30 90 53 78 0.60
6CIT (>10) 2.12 1.70–2.65 13 24 91 50 77 0.58
ISAR (≥2) 2.02 1.57–2.61 57 73 49 34 83 0.61
RR, relative risk; CI, confidence interval; PPV, positive-predictive value; NPV, negative-predictive value; AUC, area under the (receiver-operating characteristics) curve.
VMS, VeiligheidsManagementSysteem, Safety Management Programme; ADL, activities of daily living; MMSE, Mini-Mental State Examination; 6CIT, 6-item Cognitive
Impairment Test; ISAR, identification of seniors at risk.
aAdverse outcome is functional decline, death or high-healthcare demand.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3. Power to predict an adverse outcomea and its components after 3 and 12 months of follow-up using the instruments
of the Dutch Safety Management Programme VMS in combination with ageb
RR 95% CI % of population
screened positive
Sensitivity (%) Specificity (%) PPV (%) NPV (%) AUC
Initial cohort
Three-month follow-up 3.53 2.79–4.46 34 68 74 50 86 0.71
Twelve-month follow-up 3.16 2.46–4.05 34 66 72 44 86 0.69
Validation cohort
Three-month follow-up 2.60 2.15–3.15 35 61 75 57 78 0.68
VMS, Veiligheids Management Systeem= Safety Management Programme; PPV, positive-predictive value; NPV, negative-predictive value; AUC, area under the
receiver-operating characteristics curve; RR, relative risk; CI, confidence interval.
aAdverse outcome is functional decline, death or high healthcare demand.
bPatients were considered frail when aged 70–80 years and positive on three or more of the four VMS domains or aged over 80 years and positive on one or more domains.
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By using the full-original content of the previously vali-
dated instruments, we enhanced the face validity of the
screening model. The use of instruments that have been
shown to be feasible for implementation [22] is a strength
of our study. The results can be easily implemented in
Dutch hospitals by integrating the model in electronic
medical record systems and using the data collected within
the context of VMS. Another important strength is the
availability of results of 12-month follow-up measurements
as well as validation in a new cohort. Because the interview
was drastically shortened in the validation cohort, the par-
ticipation rate was enhanced. The comparison of variables
available in both cohorts showed that the comparability of
both cohorts was not affected. The fact that the study
population was mostly recruited from surgical and neuro-
logical units is a limitation of the study. Conclusions on the
performance of the suggested instrument in other patient
groups, such as patients admitted to general internal medi-
cine units, cannot be drawn. Future research should focus
on validating the results in this group of patients and other
populations.
The instrument suggested in the current paper had both
an acceptable speciﬁcity and sensitivity. The advantage of
these test characteristics is that the number of patients un-
necessarily screened positive remains manageable, while the
number of frail older patients that were missed is accept-
able. Because of the very similar predictive powers and the
widely differing sensitivities and speciﬁcities of the (combi-
nations) of existing screening instruments, a screening in-
strument must not be chosen based on its predictive power
only. The gains and costs need to be weighed carefully.
Using a sensitive instrument can cause positive-screening
results outnumbering the (ﬁnancial) capacity of follow-up
interventions in a clinical setting. The option to use a vali-
dated instrument that is more speciﬁc, but less sensitive
might be a better solution than, for example, adapting the
cut-off value of an instrument to decrease the number of
positive results. Another option would be to implement a
second step in the screening procedure once patients have
been screened positive. When using a very speciﬁc instru-
ment, extra attention is needed for the early identiﬁcation
of increased vulnerability in patients during hospital stay.
When no other instruments are available or implemented,
age can be used as a marker for frailty, as we found age to
be a strong predictor for adverse outcomes.
Concluding, the VMS-tool plus age (VMS+) offers an ef-
ﬁcient instrument to identify frail hospitalised older adults at
risk for adverse outcome. Combining information on the
separate domains of the Dutch patient safety programme led
to a fair risk-stratiﬁcation. Identifying patients at risk for
adverse outcome is only a ﬁrst step in its prevention.
Thorough and reasoned consideration with respect to the
speciﬁcity and the sensitivity of a screening instrument in re-
lation to the capacity available in clinical practice is required
to make responsible choices. It is important to accept that
the perfect screening instrument detecting older adults at
risk does not yet exist.
Key points
• The incidence rate of adverse outcomes after hospitalisa-
tion is high in older patients.
• Screening hospitalised older patients for frailty can help to
prevent adverse outcomes.
• A combination of screening instruments on four geriatric
domains (ADL, falls, undernutrition and delirium) offers
an efﬁcient instrument to identify frail older patients.
• Patients are considered frail if aged 70–80 years and three
or four of the domains are positive, or if aged over 80 years
and one or more domains are positive.
• Given the limited predictive power, costs and beneﬁts of
screening need to be carefully weighed in clinical practice.
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